Publication:
Inhibition of Polyamine Oxidase Prevented Cyclin-Dependent Kinase Inhibitor-Induced Apoptosis in HCT 116 Colon Carcinoma Cells

Loading...
Thumbnail Image

Institution Authors

Item type:Person,
ARISAN, ELİF DAMLA
Prof.Dr.
Item type:Person,
YERLİKAYA, PINAR OBAKAN
Doç.Dr.

Organizational Units

Authors

Çoker Gürkan, Ajda

Palavan Ünsal, Narçin

Advisor

item.page.editor

Editor

Department

Journal Title

Journal ISSN

Volume Title

DOI

Research Projects

Organizational Units

Journal Issue

Abstract

Roscovitine and purvalanol are novel cyclin-dependent kinase (CDK) inhibitors that prevent cell proliferation and induce apoptotic cell death in various cancer cell lines. Although a number of studies have demonstrated the potential apoptotic role of roscovitine, there is limited data about the therapeutic efficiency of purvalanol on cancer cells. The natural polyamines (PAs) putrescine, spermidine, and spermine have essential roles in the regulation of cell differentiation, growth, and proliferation, and increased levels of these compounds have been associated with cancer progression. Recently, depletion of intracellular PA levels because of modulation of PA catabolic enzymes was shown to be an indicator of the efficacy of chemotherapeutic agents. In this study, our aim was to investigate the potential role of PA catabolic enzymes in CDK inhibitor-induced apoptosis in HCT 116 colon carcinoma cells. Exposure of cells to roscovitine or purvalanol decreased cell viability in a dose- and time-dependent manner. The selected concentrations of roscovitine and purvalanol inhibited cell viability by 50 % compared with control cells and induced apoptosis by activating the mitochondria-mediated pathway in a caspase-dependent manner. However, the apoptotic effect of purvalanol was stronger than that of roscovitine in HCT 116 cells. In addition, we found that CDK inhibitors decreased PA levels and significantly upregulated expression of key PA catabolic enzymes such as polyamine oxidase (PAO) and spermine oxidase (SMO). MDL-72,527, a specific inhibitor of PAO and SMO, decreased apoptotic potential of CDK inhibitors on HCT 116 cells. Moreover, transient silencing of PAO was also reduced prevented CDK inhibitor-induced apoptosis in HCT 116 cells. We conclude that the PA catabolic pathway, especially PAO, is a critical target for understanding the molecular mechanism of CDK inhibitor-induced apoptosis.

Description

Journal or Series

ISSN

1360-8185

ISBN

Rights

Citation

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

17
Görüntülenme
0
İndirme
Google Scholar
Scholar'da Ara ↗
Bu yayında DOI yok — Altmetric/Dimensions/PlumX/BIP! rozetleri DOI gerektirir.